Randomised trial of N-acetylcysteine in laparoscopic bariatric surgery

ISRCTN ISRCTN81349394
DOI https://doi.org/10.1186/ISRCTN81349394
Secondary identifying numbers N/A
Submission date
20/12/2007
Registration date
28/02/2008
Last edited
14/06/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr A G Patel
Scientific

King's College Hospital
Denmark Hill
London
SE59RS
United Kingdom

Study information

Study designSingle-centre randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe Effect of Intraoperative N-Acetylcysteine on Hepatocellular Injury During Laparoscopic Bariatric Surgery: A Randomised Controlled Trial
Study objectivesAdministration of N-acetylcysteine before and during the period of liver retraction will prevent or decrease the degree of liver damage due to ischaemia-reperfusion injury during laparoscopic bariatric surgery.

As of 25/03/2009 this record was updated to include new trial dates; the initial trial dates were as follows:
Initial anticipated start date: 01/03/2008
Initial anticipated end date: 01/03/2010
Ethics approval(s)1. Approval granted from the King's College Hospital Research Ethics Committee on the 21/07/2008, ref: 08/H0808/2
2. Medicines and Healthcare products Regulatory Agency (MHRA) approval
Health condition(s) or problem(s) studiedMorbid obesity /non-alcoholic fatty liver disease
InterventionTreatment group: N-acetylcysteine 150 mg/kg lean body weight, intravenously as an infusion during surgery
Control group: No intervention
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)N-acetylcysteine
Primary outcome measureThe extent of hepatocellular damage and its clinical effect, measured at post-operative days 1, 2, 3 and at 6 weeks post surgery.
Secondary outcome measuresTo elucidate the mechanisms of intraoperative hepatocellular damage and the effects (if any) of N-acetylcysteine.
Overall study start date01/04/2009
Completion date31/03/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants80
Key inclusion criteria1. Male or Female
2. Aged 18 to 65
3. National Institute of Clinical Excellence criteria for morbid obesity surgery: BMI >40 or BMI >35 with obesity related complications
Key exclusion criteria1. Pregnancy
2. History of chronic liver disease, including viral hepatitis, haemachromatosis, alcoholic liver disease or known alcohol intake >20g/day
3. Previous liver surgery, e.g., resection, orthotopic transplantation
4. Psychiatric illness, including anxiety, mood and eating disorders
5. Bleeding tendency or anticoagulant medications
6. Known allergies to N-acetylcysteine or related compounds
Date of first enrolment01/04/2009
Date of final enrolment31/03/2011

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

King's College Hospital
London
SE59RS
United Kingdom

Sponsor information

King's College Hospital NHS Foundation Trust (UK)
Hospital/treatment centre

Denmark Hill
London
SE5 9RS
England
United Kingdom

Website http://www.kch.nhs.uk
ROR logo "ROR" https://ror.org/01n0k5m85

Funders

Funder type

Government

King's College Hospital NHS Foundation Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/06/2016 Yes No

Editorial Notes

14/06/2016: No publications found, verifying study status with principal investigator.